PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Ferrous Ascorbate→

Ferrous Ascorbate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
24808-52-4
Molecular formula
C12H14FeO12
Molecular weight
406.08 g/mol
Drug class
Iron replacementferrous (Fe2+) iron source
Mechanism of action
Ferrous iron is absorbed primarily in the duodenum and proximal jejunum through divalent metal transporter 1 (DMT1). Absorbed iron enters the circulating transferrin pool and is incorporated into haemoglobin, myoglobin and iron-dependent enzymes. Fumarate, sulfate, succinate and ascorbate salts deliver the same ferrous iron moiety; elemental iron content and formulation affect dosing and tolerability, not the core deficiency indication.
Indications / reported uses
  • Prevention and treatment of iron deficiency
  • Treatment of iron-deficiency anaemia, including in pregnancy where clinically appropriate; elemental iron dose and tolerability depend on the particular salt and formulation

Sources: NIH Office of Dietary Supplements — Iron fact sheet · NHS — Iron deficiency anaemia · UK product information for ferrous salts

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Ferrous Ascorbate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ferrous Ascorbate Permitted Daily Exposure (PDE) report (the Ferrous Ascorbate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ferrous Ascorbate Occupational Exposure Limit (OEL) report (the Ferrous Ascorbate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.